Very few women, however, are born with faulty fallopian tubes.
Infection is the basic problem - mostly venereal infections, such as gonorrhea and chlamydia.
As is the case with most biotechnologies, the greatest beneficiaries in IVF are not the patients. They may endure great discomfort, false hope, depression, degrading and humiliating invasive procedures, financial burden, and the short and long-term adverse effects of the various drugs and procedures involved. The real beneficiaries in IVF are the IVF scientists and the pharmaceutical companies. Their prestige and financial profits are proportionate to the number of women they coax into the program. In IVF scientists are also trying to master the fertilisation of the human egg and the growth of the human embryo without the use of a women's body.